Nippon India Pharma Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹233 Cr | ₹8346 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.35 | 1.82 |
| Manager | Rohan Korde | Sailesh Raj Bhan |
| ISIN Code | INF00XX01BL5 | INF204K01968 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -2.47% | -0.42% |
| 6 Month | -0.27% | 1.31% |
| 1 Year | -7.44% | -0.53% |
| 3 Year | 18.31% | 20.97% |
| 5 Year | - | 16.1% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | -1.44% | 0.75% |
| 1 Year | -0.1% | 6.3% |
| 3 Year | 14.59% | 16.99% |
| 5 Year | - | 16.43% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 18.94% | 16.7% |
| 3 Year | 20.21% | 20.91% |
| 5 Year | - | 20.41% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | 15.64% | 14.36% |
| Sharp | 0.77% | 0.98% |
| Beta | 0.95% | 0.87% |
| Alpha | -2.74% | 1.45% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Rohan Korde | Sailesh Raj Bhan |
| Total AUM | ₹4626 Cr | ₹96086 Cr |
| Funds Managed | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 3.94 | 0.33 |
| Large Cap | 32.04 | 49.27 |
| Mid Cap | 36.31 | 20.35 |
| Small Cap | 27.72 | 30.05 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.7 | 0.33 |
| Healthcare | 93.14 | - |
| Basic Materials | 2.87 | - |
| Industrials | 1.05 | - |
| Financial Services | 1.25 | - |
| Healthcare Services | - | 21.28 |
| Pharmaceuticals & Biotechnology | - | 75.07 |
| Retailing | - | 3.32 |
Top Comparisons
Motilal Oswal ELSS Tax Saver Fund (MOFLTE) - Regular Plan - Growth Option
3Y Returns21.43%
LIC MF ELSS Regular Plan-Growth
3Y Returns14.61%
ICICI Prudential MidCap Fund - Growth
3Y Returns21.13%
Aditya Birla Sun Life MidCap Fund-Growth
3Y Returns19.11%
Aditya Birla Sun Life Banking and Financial Services Fund - Regular Plan - Growth
3Y Returns15.32%
Baroda BNP Paribas Banking and Financial Services Fund - Regular - Growth Option
3Y Returns15.94%
Franklin U.S. Opportunities Equity Active FOF - Regular - Growth
3Y Returns24.12%
SBI US Specific Equity Active FoF - Regular Plan - Growth
3Y Returns24.77%